Bulimia Nervosa (BN) is a severe, potentially life-threatening eating disorder characterized by a cycle of binge eating followed by compensatory behaviors such as self-induced vomiting or excessive exercise. As global awareness surrounding mental health reaches new heights in 2026, the pharmacological landscape for treating BN has become a focal point for healthcare providers and inve... https://www.databridgemarketresearch.com/reports/global-bulimia-nervosa-drug-market